United Therapeutics Corp (UTHR)
235.95
-1.05
(-0.44%)
USD |
NASDAQ |
Apr 25, 16:00
236.00
+0.05
(+0.02%)
After-Hours: 20:00
United Therapeutics Cash from Investing (TTM): -719.60M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -719.60M |
| September 30, 2023 | -951.00M |
| June 30, 2023 | -731.60M |
| March 31, 2023 | -673.40M |
| December 31, 2022 | -811.50M |
| September 30, 2022 | -818.00M |
| June 30, 2022 | -959.90M |
| March 31, 2022 | -839.80M |
| December 31, 2021 | -486.90M |
| September 30, 2021 | -354.90M |
| June 30, 2021 | -390.70M |
| March 31, 2021 | -717.20M |
| December 31, 2020 | -738.50M |
| September 30, 2020 | -608.50M |
| June 30, 2020 | -635.50M |
| March 31, 2020 | -302.70M |
| December 31, 2019 | -335.40M |
| September 30, 2019 | -473.80M |
| June 30, 2019 | -505.00M |
| March 31, 2019 | -822.20M |
| December 31, 2018 | -820.60M |
| September 30, 2018 | -1.027B |
| June 30, 2018 | -897.10M |
| March 31, 2018 | -728.70M |
| December 31, 2017 | -835.60M |
| Date | Value |
|---|---|
| September 30, 2017 | -548.70M |
| June 30, 2017 | -328.40M |
| March 31, 2017 | -129.30M |
| December 31, 2016 | 48.30M |
| September 30, 2016 | 96.30M |
| June 30, 2016 | 423.80M |
| March 31, 2016 | 447.20M |
| December 31, 2015 | 503.60M |
| September 30, 2015 | 499.09M |
| June 30, 2015 | 249.44M |
| March 31, 2015 | 300.52M |
| December 31, 2014 | 338.50M |
| September 30, 2014 | 130.15M |
| June 30, 2014 | -143.62M |
| March 31, 2014 | -199.23M |
| December 31, 2013 | -294.97M |
| September 30, 2013 | -303.32M |
| June 30, 2013 | -79.88M |
| March 31, 2013 | -106.74M |
| December 31, 2012 | -163.36M |
| September 30, 2012 | 17.51M |
| June 30, 2012 | -88.06M |
| March 31, 2012 | -131.99M |
| December 31, 2011 | -121.33M |
| September 30, 2011 | -200.82M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-959.90M
Minimum
Jun 2022
-302.70M
Maximum
Mar 2020
-634.42M
Average
-673.40M
Median
Mar 2023
Cash from Investing (TTM) Benchmarks
| Liquidia Corp | -11.29M |
| Esperion Therapeutics Inc | 42.50M |
| Vertex Pharmaceuticals Inc | -3.142B |
| Heron Therapeutics Inc | 18.00M |
| Aldeyra Therapeutics Inc | 30.00M |